DriversWork ExperiencePersonal projectsTimelinePublicationsThis site

Publications

Journal articles - First author

  • Dutton, P., Love, S. B., Billingham, L., & Hassan, A. B. (2016). Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing'`s sarcoma. Statistical methods in medical research, 962280216662070. doi:10.1177/0962280216662070

Journal articles - Author

  • Wasan, H. S., Gibbs, P., Sharma, N. K., Taieb, J., Heinemann, V., Ricke, J., . . . Sharma, R. A. (2017). First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. The Lancet. Oncology, 18(9), 1159-1171. doi:10.1016/s1470-2045(17)30457-6
  • Odutayo, A., Emdin, C. A., Hsiao, A. J., Shakir, M., Copsey, B., Dutton, S., . . . Hopewell, S. (2017). Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials-ESORT).. BMJ (Clinical research ed.), 356, j917. doi:10.1136/bmj.j917
  • Hopewell, S., Boutron, I., Altman, D. G., Barbour, G., Moher, D., Montori, V., . . . Ravaud, P. (2016). Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial.. BMC medicine, 14(1), 199. doi:10.1186/s12916-016-0736-x
  • Domingo, E., Freeman-Mills, L., Rayner, E., Glaire, M., Briggs, S., Vermeulen, L., . . . Church, D. N. (2016). Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study. The lancet. Gastroenterology & hepatology, 1(3), 207-216. doi:10.1016/s2468-1253(16)30014-0
  • Carrington, R., Spezi, E., Gwynne, S., Dutton, P., Hurt, C., Staffurth, J., & Crosby, T. (2016). The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial.. Radiation oncology (London, England), 11, 19. doi:10.1186/s13014-016-0594-x
  • Hurt, C. N., Mukherjee, S., Bridgewater, J., Falk, S., Crosby, T., McDonald, A., . . . Johnson, C. (2015). Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer.. International journal of radiation oncology, biology, physics, 93(4), 810-818. doi:10.1016/j.ijrobp.2015.08.026
  • Tristram, A., Hurt, C. N., Madden, T., Powell, N., Man, S., Hibbitts, S., . . . Griffiths, G. (2014). Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial. The Lancet. Oncology, 15(12), 1361-1368. doi:10.1016/s1470-2045(14)70456-5
  • Borley, A., Mercer, T., Morgan, M., Dutton, P., Barrett-Lee, P., Brunelli, M., & Jasani, B. (2014). Impact of HER2 copy number in IHC2+/FISH-amplified breast cancer on outcome of adjuvant trastuzumab treatment in a large UK cancer network. British journal of cancer, 110(8), 2139-2143. doi:10.1038/bjc.2014.147

Conference items - Presenting author

  • Dutton, P., Love, S., Faleti, A., & Hassan, B. (2015). The use of Bayesian design in two trials in rare cancers. In TRIALS Vol. 16.

Conference items - Author

  • Wasan, H., van Hazel, G., Heinemann, V., Sharma, N., Taieb, J., Ricke, J., . . . Gibbs, P. (2017). O-027Overall survival analysis of the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer. In Annals of Oncology Vol. 28. doi:10.1093/annonc/mdx262.026
  • Harpreet, W., Guy, V. H., Volker, H., Navesh, S., Julien, T., Jens, R., . . . Investigator, F. -G. T. (2017). Overall survival analysis of the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer. In ANNALS OF ONCOLOGY Vol. 28.
  • Virdee, P., Love, S., Dutton, P., & Moschandreas, J. (2016). Interpretation of effect estimates in competing risks survival models: A simulated analysis of organ-specific progression-free survival in a randomised phase III cancer trial. ISCB 2016 conference (Birmingham).
  • Carrington, R., Spezi, E., Gwynne, S., Dutton, P., Hurt, C., Crosby, T., & Staffurth, J. (2015). TH-AB-304-11: The Influence of Radiotherapy Treatment Method On Dose Distribution and Its Relation to Patient Outcome in the SCOPE 1 Oesophageal Cancer Trial Using Type B Algorithms. In Medical physics Vol. 42 (pp. 3703). doi:10.1118/1.4926126
  • Mukherjee, S., Hurt, C., Dutton, P., Bridgewater, J. A., Crosby, T., Mcdonald, A., . . . Griffiths, G. (2014). Impact of gemcitabine (Gem)-or capecitabine (Cape)-based chemoradiation (CRT) on health-relatedquality of life (HRQL) in patients with locally advanced pancreatic cancer (LAPC): Outcomes from the randomized phase II SCALOP trial. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32.
  • Virdee, P., Dutton, P., Love, S., Wasan, H., Sharma, R. A., & Moschandreas, J. (n.d.). Interpretation of effect estimates in competing risks survival models: A simulated analysis of organ-specific progression-free survival in a randomised phase III cancer trial.
  • Sharma, N., Gibbs, P., Van Hazel, G., Heinemann, V., Ricke, J., Findlay, M., . . . Sharma, R. S. (n.d.). The FOXFIRE/SIRFLOX/FOXFIRE-Global randomised studies of first-line selective internal radiation therapy for metastatic colorectal cancer. In European Association of Nuclear Medicine.